BIOMARIN PHARMACEUTICAL INC Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 69.70 | 9 | 627 | 68,733 | 68.7 K to 68.7 K (-0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 69.83 | 9 | 628 | 68,742 | 68.8 K to 68.7 K (-0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 62.18 | 7 | 435 | 68,751 | 68.7 K to 68.8 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 62.17 | 7 | 435 | 68,744 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 58.78 | 8 | 470 | 68,737 | 68.7 K to 68.7 K (-0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 58.02 | 3 | 174 | 68,745 | 68.7 K to 68.7 K (0.00 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 82.93 | 12 | 995 | 68,748 | 68.8 K to 68.7 K (-0.02 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 65.89 | 8 | 527 | 68,760 | 68.8 K to 68.8 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 65.75 | 5 | 329 | 68,752 | 68.7 K to 68.8 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 66.48 | 4 | 266 | 68,747 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 74.84 | 6 | 449 | 68,743 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 74.07 | 5 | 370 | 68,737 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 70.30 | 7 | 492 | 68,732 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 70.06 | 8 | 560 | 68,725 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 58.85 | 9 | 530 | 68,717 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 58.57 | 9 | 527 | 68,708 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 61.43 | 4 | 246 | 68,699 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 61.99 | 5 | 310 | 68,695 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 61.38 | 7 | 430 | 68,690 | 68.7 K to 68.7 K (+0.01 %) |
| Feb 10 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 61.48 | 7 | 430 | 68,683 | 68.7 K to 68.7 K (+0.01 %) |